Switch View
© BusinessWire
28.10.2025
ISIN: US6047491013
Mirum Pharmaceuticals Inc
TKOMF
LISTED
OTC
Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it will report third quarter 2025 financial results on November 4, 2025. Mirum will also host a conference call to discuss the third quarter 2025 financial results and recent corporate progress.
Conference call details:
Tuesday November 4th, 2025
4:30 p.m. ET / 1:30 p.m. PT
Dial-In:...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US64125C1099
Neurocrine Biosciences Inc
NBIX
LISTED
NASDAQ
Neurocrine Biosciences Reports Third Quarter 2025 Financial Results
News Preview
Achieved Total Net Product Sales of $790 Million Representing 28% Year-Over-Year Growth
INGREZZA® (valbenazine) Third-Quarter 2025 Net Product Sales of $687 Million Representing 12% Year-Over-Year Growth
CRENES...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
News Preview
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that it will release its financial results for the quarter ended September 30, 2025 after the mark...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
28.10.2025
ISIN: US98160J1088
MariMed Inc.
MRMD
LISTED
CSE
MariMed Announces Strategic Exit From Missouri Market
News Preview
MariMed exits Missouri market....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
28.10.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US00972D1054
Akebia Therapeutics Inc
AKBA
LISTED
NASDAQ
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
News Preview
Akebia does not expect to initiate VALOR clinical trial following Type C meeting feedback from U.S. FDA Akebia does not expect to initiate VALOR clinical trial following Type C meeting feedback from U.S. FDA...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: AU000000AVH4
Avita Medical Inc.
AVH
LISTED
ASX
AVITA Medical Welcomes Support for RECELL® in Burns in Australia
News Preview
MSAC backs AVITA Medical’s RECELL® for burns, recognizing its safety, healing benefits, donor site sparing, and reduced hospital stays....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US90400D1081
Ultragenyx Pharmaceutical Inc
RARE
LISTED
NASDAQ
Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update
News Preview
NOVATO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, November 4, 2025, to disc...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”). DexCom is a medical device company.
For more information, submit a fo...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Reports Third Quarter 2025 Financial Results
News Preview
Châtillon, France, October 28, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US68554V1089
OraSure Technologies Inc
OSUR
LISTED
NASDAQ
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
News Preview
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US16359R1032
Chemed Corp
CHE
LISTED
NYSE
Chemed Reports Third-Quarter 2025 Results
News Preview
CINCINNATI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quar...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
28.10.2025
ISIN: US53228F1012
LifeStance Health Group Inc
LFST
LISTED
NASDAQ
LifeStance to Present at the UBS Global Healthcare Conference
News Preview
SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted in Palm Beach Gardens, FL....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US68752L1008
OrthoPediatrics Corp
KIDS
LISTED
NASDAQ
OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results
News Preview
Increased Third Quarter 2025 Revenue 12% Year-over-year, and Increased Adjusted EBITDA by 56% year-over-year Increased Third Quarter 2025 Revenue 12% Year-over-year, and Increased Adjusted EBITDA by 56% year-over-year...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US10950A1060
Brightspring Health Services Inc.
BTSG
LISTED
NASDAQ
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
News Preview
LOUISVILLE, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2025, increased Revenue guidance, and reiterated...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US87357P1003
Tactile Systems Technology Inc
TCMD
LISTED
NASDAQ
Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
News Preview
MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the presentation of new six-month clinical data during the late-breaking poster session at the American Congress of R...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US92854B1098
Vivani Medical, Inc.
VANI
LISTED
NASDAQ
Vivani Medical, Inc. Announces Closing of Common Stock Offering
News Preview
ALAMEDA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the closing of its previously announced best efforts registered direct offering of 6,000,000 shares of its common stoc...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US08659B1026
Beta Bionics, Inc.
BBNX
LISTED
NASDAQ
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
News Preview
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended September 30, 2025 and raised its full year guidance for the year ending December 31, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Deadline: SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASD...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
News Preview
New AI capabilities will help scientists
identify, optimize and validate new molecules
Additional applications include manufacturing, medical imaging and enterprise AI agents
INDIANAPOLIS, Oct...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Oct. 28, 2025 /PRNewswire/ -- The Ademi Firm is investigating Avidity (Nasdaq: RNA) for possible breaches of fiduciary duty and other violations of law in its transaction with Novartis....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Kuehn Law Encourages Investors of Neogen Corporation to Contact Law Firm
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Neogen Corporation (NASDAQ: NEOG) breached their fiduciary duties to shareholders....
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), is investigating claims on behalf of investors of Organon & Co. (NYSE: OGN). Such investors are advised to contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Johnson Fistel Announces Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH) on Behalf of Investors
News Preview
DENVER, Oct. 28, 2025 /PRNewswire/ -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Lantheus Holdings, Inc. (NASDAQ: LNTH). The lawsuit seeks to recover losses on behalf of investors who purchased the Company's securities between February 26, 2025 and August 5,...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Law Offices of Frank R. Cruz Encourages Baxter International, Inc. (BAX) Shareholders to Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”). Baxter investors have until December 15, 2025 to file a lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages MoonLake Immunotherapeutics (MLTX) Shareholders to Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”). MoonLake investors have until December 15, 2025 to file a...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: CNE100003PG4
Pharmaron Beijing Co., Ltd.
3759
LISTED
HKSE
Pharmaron Acquires Biortus in China
News Preview
Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (hereinafter referred to as “Pharmaron” and the “Company”) today announced that it has entered into a definitive Share Purchase Agreement to acquire 82.54% equity interest of Biortus Biosciences Co., Ltd. and its affiliates (hereinafter referred to as "Biortus"). The transaction is exp...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US3724463027
Genprex, Inc.
GNPX
LISTED
NASDAQ
Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules
News Preview
$3.4 million upfront with up to an additional $6.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
AUSTIN, Texas, Oct. 28, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
News Preview
Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
Industry expert with many years of experience in the sector, including around 26 years in management positions at Gerresheimer
Dietmar Siemssen to step down as CEO by mutual agreement with the Supervisory Board
New formation of the Management Board
Duesseldorf, October 2......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
News Preview
Gerresheimer: Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
Industrieexperte mit langjähriger Branchenerfahrung, darunter rund 26 Jahre aus Managementpositionen bei Gerresheimer
Dietmar Siemssen legt im Einvernehmen mit dem Aufsichtsrat sein Amt als CEO nieder
Personelle Neuaufstellung des Vorstands
Düsseldorf, 28. Oktober 2025. ......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
News Preview
Gerresheimer AG: Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
Düsseldorf, 28. Oktober 2025. Der Aufsichtsrat der Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer"), hat Uwe Röhrhoff mit Wirkung zum 1. November 2025 als Interims-CEO in den Vorstand der Gesellschaft berufen. Er folgt auf Dietmar Siemssen, der sein Amt als CEO der ......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
News Preview
Gerresheimer AG: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
Duesseldorf, October 28, 2025. The Supervisory Board of Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") has appointed Uwe Röhrhoff as the interim CEO of the Management Board, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO of Ger......
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Deadline Today: Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action First Filed by the Firm – SMLR
News Preview
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”), of the important October 28, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
So what: If you...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US03828A1016
Applied Therapeutics Inc
APLT
LISTED
NASDAQ
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Applied Therapeutics, Inc. (NASDAQ: APLT) breached their fiduciary duties to shareholders.
If you currently own Applied stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KYG4403H1002
Hbm Holdings Limited
2142
LISTED
HKSE
Harbour BioMed Launches First Fully Human Generative AI HCAb Model to Accelerate Next-Generation Biologics Discovery
News Preview
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the launch of its first fully human Generative A...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
News Preview
Positive FDA meeting...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US83086J2006
Skye Bioscience Inc
SKYE
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ: SKYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0144421072
Alector Inc
ALEC
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc. - ALEC
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alector, Inc. ("Alector" or the "Company") (NASDAQ: ALEC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Baxter International, Inc. of Class Action Lawsuit and Upcoming Deadlines - BAX
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler" or the "Company") (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly announces roster of Team USA athletes for the Olympic and Paralympic Games Milano Cortina 2026, pledges to translate U.S. Olympic and Paralympic milestones into meaningful community impact
News Preview
INDIANAPOLIS, Oct. 28, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its roster of Team USA athletes for the Olympic and Paralympic Winter Games Milano Cortina 2026, reaffirming its mission to support athletes' holistic health and translate their achievements into meaningful impact for co...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: GB00BRS65X63
Indivior plc
INDV
LISTED
LSE
Indivior to Participate in the Stifel 2025 Healthcare Conference
News Preview
RICHMOND, Va., Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference:...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in MoonLake Immunotherapeutics of Class Action Lawsuit and Upcoming Deadlines - MLTX
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ: MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free,...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0042251084
ACADIA Pharmaceuticals Inc
ACAD
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ: ACAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines - CYTK
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ: CYTK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) and certain officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 2...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lantheus Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - LNTH
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYR
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Tho...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US68621F1021
Organogenesis Holdings Inc
ORGO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcturus Therapeutics Holdings Inc. ("Arcturus" or the "Company") (NASDAQ: ARCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Molina Healthcare, Inc. of Class Action Lawsuit and Upcoming Deadlines - MOH
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 79...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of I-Mab ("I-Mab" or the "Company") (NASDAQ: IMAB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Savara between March 7, 2024 and May 23, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in MoonLake between March 10, 2024 and Septem...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Lantheus between February 26, 2025 and Aug...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Baxter between February 23, 2022 and July 30...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
